Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 23Recruiting 6Terminated 5Withdrawn 3Unknown 3Active not recruiting 2Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinsonian Disorders 1Neoplasms 1Glioma 1Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

Specimen Handling 3Blood Specimen Collection 2somapacitan 1pembrolizumab 1ibrutinib 1gallium 68 PSMA-11 1fluorodopa F 18 1exemestane 1durvalumab 1Tumor Burden 1Telemedicine 1Tamoxifen 1Standard of Care 1Semen Analysis 1Radiography, Panoramic 1Protons 1Physical Examination 1Photons 1Music Therapy 1Magnetic Resonance Spectroscopy 1Letrozole 1JNJ-64619178 1JNJ-64264681 1High-Intensity Interval Training 1Exercise 1Esophagectomy 1Electrocardiography 1Community Health Workers 1Angptl4 protein, mouse 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Neoplasms × Magnetic Resonance Spectroscopy × Clear all
NCT07542158 2026-04-21

Ultralow Dose PET Imaging of 18F-FDOPA

Nuclear Imaging Institute

Phase 2 Enrolling by invitation
200 enrolled
CNS

Glioma, Neoplasms, Parkinsonian Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡